• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两条不同的信号通路以不依赖酪蛋白激酶II的方式激活p53的潜在DNA结合功能。

Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner.

作者信息

Hupp T R, Lane D P

机构信息

Department of Biochemistry, Dundee University, Scotland.

出版信息

J Biol Chem. 1995 Jul 28;270(30):18165-74. doi: 10.1074/jbc.270.30.18165.

DOI:10.1074/jbc.270.30.18165
PMID:7629129
Abstract

Post-translational modification of a carboxyl-terminal negative regulatory domain in vitro by either casein kinase II or protein kinase C allosterically activates the latent sequence-specific DNA binding function of p53. Reported here is a biochemical approach to determine the types of signaling pathways and enzymes that are involved in p53 activation in cells. Using a novel chromatographic method, we have been able to separate three distinct biochemical forms of p53 that have been synthesized in vivo; two are in an activated state, and one is in a latent state for sequence-specific DNA binding. The two activated forms of p53 appear to be controlled individually by either a constitutive or a UV-inducible signaling pathway. p53 lacking the COOH-terminal casein kinase II site (p53 delta 4) was characterized biochemically and used to determine the affects of deletion of the casein kinase II motif on the production of the two activated forms of p53 in vivo. As observed with full-length p53, the production of two distinct chromatographic forms of activated p53 delta 4 occurs in vivo, indicating that p53 activation can occur through a casein kinase II-independent pathway and suggesting that two other factors are involved in activation of p53 in vivo.

摘要

酪蛋白激酶II或蛋白激酶C在体外对p53羧基末端负调控域进行的翻译后修饰可别构激活p53潜在的序列特异性DNA结合功能。本文报道了一种生化方法,用于确定细胞中参与p53激活的信号通路和酶的类型。使用一种新型色谱方法,我们能够分离出体内合成的三种不同生化形式的p53;两种处于激活状态,一种处于序列特异性DNA结合的潜伏状态。p53的两种激活形式似乎分别由组成型或紫外线诱导型信号通路单独控制。缺乏COOH末端酪蛋白激酶II位点的p53(p53δ4)经过生化表征,并用于确定酪蛋白激酶II基序缺失对体内两种激活形式的p53产生的影响。正如全长p53所观察到的那样,体内会产生两种不同色谱形式的激活型p53δ4,这表明p53激活可以通过酪蛋白激酶II非依赖性途径发生,并表明体内p53激活还涉及另外两个因素。

相似文献

1
Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner.两条不同的信号通路以不依赖酪蛋白激酶II的方式激活p53的潜在DNA结合功能。
J Biol Chem. 1995 Jul 28;270(30):18165-74. doi: 10.1074/jbc.270.30.18165.
2
Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases.蛋白激酶对p53的隐蔽序列特异性DNA结合功能的调控。
Cold Spring Harb Symp Quant Biol. 1994;59:195-206. doi: 10.1101/sqb.1994.059.01.024.
3
Small peptides activate the latent sequence-specific DNA binding function of p53.小肽激活p53潜在的序列特异性DNA结合功能。
Cell. 1995 Oct 20;83(2):237-45. doi: 10.1016/0092-8674(95)90165-5.
4
Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.p53的特异性DNA结合不依赖于酪蛋白激酶II位点丝氨酸389处的突变。
Oncogene. 1994 Oct;9(10):3067-70.
5
Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.蛋白激酶CK2可消除蛋白激酶C对潜在p53蛋白DNA结合能力的激活作用。
Biochem J. 2004 Mar 15;378(Pt 3):939-47. doi: 10.1042/BJ20030662.
6
Conformation-dependent phosphorylation of p53.p53的构象依赖性磷酸化
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1686-91. doi: 10.1073/pnas.94.5.1686.
7
Modulation of p53 binding to Holliday junctions and 3-cytosine bulges by phosphorylation events.
Biochemistry. 2005 Feb 22;44(7):2536-44. doi: 10.1021/bi048700u.
8
Allosteric activation of latent p53 tetramers.潜在p53四聚体的变构激活
Curr Biol. 1994 Oct 1;4(10):865-75. doi: 10.1016/s0960-9822(00)00195-0.
9
DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site.DNA损伤引发人p53在CK2位点的DRB抗性磷酸化。
Oncogene. 1998 Aug 27;17(8):1045-52. doi: 10.1038/sj.onc.1202014.
10
Regulation of the DNA binding of p53 by its interaction with protein kinase CK2.p53与蛋白激酶CK2相互作用对其DNA结合的调控。
FEBS Lett. 1997 May 12;408(1):99-104. doi: 10.1016/s0014-5793(97)00399-2.

引用本文的文献

1
RNA-Seq Transcriptome Analysis of Differentiated Human Oligodendrocytic MO3.13 Cells Shows Upregulation of Genes Involved in Myogenesis.分化人少突胶质细胞 MO3.13 细胞的 RNA-Seq 转录组分析显示肌发生相关基因上调。
Int J Mol Sci. 2022 May 25;23(11):5969. doi: 10.3390/ijms23115969.
2
Semisynthetic 'designer' p53 sheds light on a phosphorylation-acetylation relay.半合成“定制”p53揭示了磷酸化-乙酰化信号传递机制。
Chem Sci. 2021 May 19;12(24):8563-8570. doi: 10.1039/d1sc00396h.
3
Understanding p53 functions through p53 antibodies.通过 p53 抗体了解 p53 功能。
J Mol Cell Biol. 2019 Apr 1;11(4):317-329. doi: 10.1093/jmcb/mjz010.
4
Mutant TP53 posttranslational modifications: challenges and opportunities.突变型TP53的翻译后修饰:挑战与机遇
Hum Mutat. 2014 Jun;35(6):738-55. doi: 10.1002/humu.22506. Epub 2014 Feb 11.
5
A novel p53 phosphorylation site within the MDM2 ubiquitination signal: I. phosphorylation at SER269 in vivo is linked to inactivation of p53 function.一个位于 MDM2 泛素化信号中的新型 p53 磷酸化位点:I. 体内 SER269 的磷酸化与 p53 功能失活有关。
J Biol Chem. 2010 Nov 26;285(48):37762-72. doi: 10.1074/jbc.M110.143099. Epub 2010 Sep 17.
6
A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. a model in which phosphorylation at SER269 induces a mutant conformation to p53.一种新型 p53 磷酸化位点位于 MDM2 泛素化信号内:II. 在该模型中,SER269 位点的磷酸化会诱导 p53 发生突变构象。
J Biol Chem. 2010 Nov 26;285(48):37773-86. doi: 10.1074/jbc.M110.143107. Epub 2010 Sep 16.
7
Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.爱泼斯坦-巴尔病毒核抗原3C靶向p53并调节其转录和凋亡活性。
Virology. 2009 Jun 5;388(2):236-47. doi: 10.1016/j.virol.2009.03.027. Epub 2009 Apr 24.
8
Posttranslational phosphorylation of mutant p53 protein in tumor development.肿瘤发生过程中突变型p53蛋白的翻译后磷酸化
Med Mol Morphol. 2006 Jun;39(2):79-87. doi: 10.1007/s00795-006-0320-0.
9
Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.肿瘤抑制蛋白p53对新型抗肿瘤三核铂药物BBR3464和顺铂修饰的DNA的差异识别。
Nucleic Acids Res. 2004 Oct 14;32(18):5546-52. doi: 10.1093/nar/gkh896. Print 2004.
10
Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.蛋白激酶CK2可消除蛋白激酶C对潜在p53蛋白DNA结合能力的激活作用。
Biochem J. 2004 Mar 15;378(Pt 3):939-47. doi: 10.1042/BJ20030662.